Abstract

IntroductionThe establishment of a legal market for medicinal cannabis under the Dangerous Drugs Amendment Act 2015 has positioned Jamaica at the forefront of cannabis law reform in the developing world. Many local cannabis businesses have attracted investment from overseas, including from Canada, US and Europe.AimTo explore the opportunities and risks of foreign investment in an emerging domestic legal cannabis market in a developing country.MethodsThematic analysis of semi-structured face-to-face interviews with 22 key informants (KIs) from the Jamaican government, local cannabis industry, academia and civil society, and field observations of legal and illegal cannabis cultivators.ResultsKIs from the Jamaican public agencies and domestic cannabis entrepreneurs saw foreign investment as an essential source of capital to finance the start-up costs of legal cannabis businesses. Local cannabis entrepreneurs prioritised investors with the greatest financial resources, brand reputation and export networks. They also considered how allied an investor was with their business vision (e.g., organic cultivation, medical vs. recreational). The key benefits of partnering with a foreign investor included transfer of technical knowledge and financial capital, which enhanced production, quality assurance and seed-to-sale tracking. Some KIs expressed concern over investors’ focus on increasing production efficiency and scale at the expense of funding research and development (R&D) and clinical trials. KIs from the local industry, government agencies and civil society highlighted the risks of ‘predatory’ shareholder agreements and domestic political interference. Concerns were raised about the impact of foreign investment on the diversity of the domestic cannabis sector in Jamaica, including the commitment to transition traditional illegal small-scale cannabis cultivators to the legal sector.ConclusionWhile foreign investment has facilitated the commercialisation of the cannabis sector in Jamaica, regulatory measures are also needed to protect the domestic industry and support the transition of small-scale illegal cultivators to the legal regime. Foreign investments may alter the economic, social and political determinants of health in transitioning from illegal to legal cannabis market economy.

Highlights

  • The establishment of a legal market for medicinal cannabis under the Dangerous Drugs Amendment Act 2015 has positioned Jamaica at the forefront of cannabis law reform in the developing world

  • Local industry key informants (KIs) and public official KIs saw foreign direct investment as an essential source of capital to finance the start-up costs of medicinal cannabis businesses

  • Securing domestic partnerships proved challenging due to Jamaican banks’ refusal to service the cannabis sector

Read more

Summary

Introduction

The establishment of a legal market for medicinal cannabis under the Dangerous Drugs Amendment Act 2015 has positioned Jamaica at the forefront of cannabis law reform in the developing world. Canadian-based Canopy GrowthTM holds licenses for cultivation and production in Europe (Denmark) and South America (Colombia) (having recently exited operations in South Africa and Lesotho), with access to more cannabis markets via joint ventures and partnerships across the world [10, 11]. Other Canadian-based cannabis companies have adopted a similar global trade model: Cronos GroupTM operates across five continents (including joint ventures in Israel, Colombia and Australia), AuroraTM is present in 25 countries; and AphriaTM (which announced a merger with TilrayTM in 2020) operates in at least ten countries [3, 4, 18]. The constraints of the United Nations international drug control treaties and the relatively small number of jurisdictions where recreational cannabis use is legal currently limit the extent of the global trade in cannabis to medicinal and scientific sectors only. The interrelationship between the medicinal and recreational cannabis sectors is becoming increasingly clear [27] and some cannabis firms in legal jurisdictions trade in both medicinal and recreational cannabis markets

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call